Intracellular Stock Forecast - 4 Period Moving Average

ITCI
 Stock
  

USD 54.08  0.63  1.18%   

Intracellular Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Intracellular historical stock prices and determine the direction of Intracellular Th's future trends based on various well-known forecasting models. However, solely looking at the historical price movement is usually misleading. Macroaxis recommends to always use this module together with analysis of Intracellular historical fundamentals such as revenue growth or operating cash flow patterns. Although Intracellular naive historical forecasting may sometimes provide an important future outlook for the firm we recommend to always cross-verify it against solid analysis of Intracellular Th systematic risk associated with finding meaningful patterns of Intracellular fundamentals over time.
Please see Historical Fundamental Analysis of Intracellular to cross-verify your projections.
  
The current PPandE Turnover is estimated to increase to 47.73. The current Accounts Payable Turnover is estimated to increase to 12.74. The current Weighted Average Shares is estimated to increase to about 87.7 M. The current Weighted Average Shares Diluted is estimated to increase to about 87.7 M.
Most investors in Intracellular cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the Intracellular's time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets Intracellular's price structures and extracts relationships that further increase the generated results' accuracy.
A four-period moving average forecast model for Intracellular Th is based on an artificially constructed daily price series in which the value for a given day is replaced by the mean of that value and the values for four preceding and succeeding time periods. This model is best suited to forecast equities with high volatility.

Intracellular 4 Period Moving Average Price Forecast For the 5th of December

Given 90 days horizon, the 4 Period Moving Average forecasted value of Intracellular Th on the next trading day is expected to be 53.92 with a mean absolute deviation of 1.35, mean absolute percentage error of 3.27, and the sum of the absolute errors of 76.99.
Please note that although there have been many attempts to predict Intracellular Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Intracellular's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Intracellular Stock Forecast Pattern

Backtest IntracellularIntracellular Price PredictionBuy or Sell Advice 

Intracellular Forecasted Value

In the context of forecasting Intracellular's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Intracellular's downside and upside margins for the forecasting period are 50.92 and 56.93, respectively. We have considered Intracellular's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value 54.08
53.92
Expected Value
56.93
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the 4 Period Moving Average forecasting method's relative quality and the estimations of the prediction error of Intracellular stock data series using in forecasting. Note that when a statistical model is used to represent Intracellular stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria111.9425
BiasArithmetic mean of the errors -0.1339
MADMean absolute deviation1.3506
MAPEMean absolute percentage error0.0279
SAESum of the absolute errors76.985
The four period moving average method has an advantage over other forecasting models in that it does smooth out peaks and troughs in a set of daily price observations of Intracellular. However, it also has several disadvantages. In particular this model does not produce an actual prediction equation for Intracellular Th and therefore, it cannot be a useful forecasting tool for medium or long range price predictions

Predictive Modules for Intracellular

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Intracellular Th. Regardless of method or technology, however, to accurately forecast the stock or bond market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Intracellular's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Intracellular in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
51.0254.0257.02
Details
Intrinsic
Valuation
LowReal ValueHigh
50.8353.8356.83
Details
7 Analysts
Consensus
LowTarget PriceHigh
46.0060.0085.00
Details
Earnings
Estimates (5)
LowProjected EPSHigh
-3.53-3.46-3.32
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Intracellular. Your research has to be compared to or analyzed against Intracellular's peers to derive any actionable benefits. When done correctly, Intracellular's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Intracellular Th.

Other Forecasting Options for Intracellular

For every potential investor in Intracellular, whether a beginner or expert, Intracellular's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Intracellular Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Intracellular. Basic forecasting techniques help filter out the noise by identifying Intracellular's price trends.

Intracellular Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Intracellular stock to make a market-neutral strategy. Peer analysis of Intracellular could also be used in its relative valuation, which is a method of valuing Intracellular by comparing valuation metrics with similar companies.
Arbutus Biopharma CorpACADIA PharmaceuticalsAbbVie IncAbeona TherapeuticsAcorda TherapeuticsAC ImmuneAgilent TechnologiesAchieve Life SciencesAMN Healthcare ServicesTwist Bioscience CorpFreedom Holding CorpGlobal X NASDAQFRANKLIN MUTUAL EUROPEANBHP Group LimitedNatural Health Trend
 Risk & Return  Correlation

Intracellular Th Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Intracellular's price movements, , a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Intracellular's current price.

Intracellular Market Strength Events

Market strength indicators help investors to evaluate how Intracellular stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Intracellular shares will generate the highest return on investment. By undertsting and applying Intracellular stock market strength indicators, traders can identify Intracellular Th entry and exit signals to maximize returns.

Intracellular Risk Indicators

The analysis of Intracellular's basic risk indicators is one of the essential steps in helping accuretelly forecast its future price. The process involves identifying the amount of risk involved in Intracellular's investment and either accepting that risk or mitigating it. Along with some funamental techniques of forecasting Intracellular stock price, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stock investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Intracellular in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Intracellular's short interest history, or implied volatility extrapolated from Intracellular options trading.

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Intracellular Th using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please see Historical Fundamental Analysis of Intracellular to cross-verify your projections. Note that the Intracellular Th information on this page should be used as a complementary analysis to other Intracellular's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for Intracellular Stock analysis

When running Intracellular Th price analysis, check to measure Intracellular's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intracellular is operating at the current time. Most of Intracellular's value examination focuses on studying past and present price action to predict the probability of Intracellular's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Intracellular's price. Additionally, you may evaluate how the addition of Intracellular to your portfolios can decrease your overall portfolio volatility.
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Is Intracellular's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Intracellular. If investors know Intracellular will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Intracellular listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Intracellular Th is measured differently than its book value, which is the value of Intracellular that is recorded on the company's balance sheet. Investors also form their own opinion of Intracellular's value that differs from its market value or its book value, called intrinsic value, which is Intracellular's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Intracellular's market value can be influenced by many factors that don't directly affect Intracellular's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Intracellular's value and its price as these two are different measures arrived at by different means. Investors typically determine Intracellular value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Intracellular's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.